Kathrin U. Jansen

13.5k total citations
84 papers, 4.1k citations indexed

About

Kathrin U. Jansen is a scholar working on Epidemiology, Infectious Diseases and Microbiology. According to data from OpenAlex, Kathrin U. Jansen has authored 84 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Epidemiology, 31 papers in Infectious Diseases and 18 papers in Microbiology. Recurrent topics in Kathrin U. Jansen's work include Pneumonia and Respiratory Infections (47 papers), Respiratory viral infections research (39 papers) and Pneumocystis jirovecii pneumonia detection and treatment (17 papers). Kathrin U. Jansen is often cited by papers focused on Pneumonia and Respiratory Infections (47 papers), Respiratory viral infections research (39 papers) and Pneumocystis jirovecii pneumonia detection and treatment (17 papers). Kathrin U. Jansen collaborates with scholars based in United States, Germany and United Kingdom. Kathrin U. Jansen's co-authors include Annaliesa S. Anderson, William C. Gruber, Daniel A. Scott, Alejandra Gurtman, Ingrid L. Scully, Charles Knirsch, Emilio A. Emini, David Cooper, Beate Schmöele-Thoma and Michael W. Pride and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Kathrin U. Jansen

82 papers receiving 3.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kathrin U. Jansen United States	39	2.7k	1.0k	758	662	529	84	4.1k
Krzysztof Trzciński Netherlands	36	2.7k 1.0×	935 0.9×	1.2k 1.6×	811 1.2×	324 0.6×	88	4.2k
Malcolm Guiver United Kingdom	34	2.6k 1.0×	1.0k 1.0×	1.3k 1.7×	467 0.7×	336 0.6×	88	3.9k
Daniel A. Scott United States	42	3.7k 1.4×	1.1k 1.1×	1.3k 1.7×	280 0.4×	411 0.8×	162	5.4k
Gregory J. Tyrrell Canada	36	2.1k 0.8×	1.5k 1.4×	700 0.9×	573 0.9×	280 0.5×	161	4.2k
Daniela M. Ferreira United Kingdom	32	2.2k 0.8×	521 0.5×	980 1.3×	519 0.8×	554 1.0×	101	3.3k
Susan E. Richardson Canada	46	2.8k 1.0×	2.7k 2.7×	739 1.0×	576 0.9×	471 0.9×	163	5.8k
Claudette M. Thompson United States	35	2.8k 1.0×	529 0.5×	1.2k 1.6×	407 0.6×	1.1k 2.1×	74	4.0k
Stuart C. Clarke United Kingdom	33	2.6k 1.0×	684 0.7×	1.5k 2.0×	667 1.0×	181 0.3×	179	4.3k
Alex van Belkum Netherlands	32	1.8k 0.7×	1.4k 1.4×	613 0.8×	777 1.2×	165 0.3×	67	3.7k
A Goudeau France	36	3.1k 1.2×	1.0k 1.0×	332 0.4×	515 0.8×	487 0.9×	177	4.9k

Countries citing papers authored by Kathrin U. Jansen

Since Specialization

Citations

This map shows the geographic impact of Kathrin U. Jansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathrin U. Jansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathrin U. Jansen more than expected).

Fields of papers citing papers by Kathrin U. Jansen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathrin U. Jansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathrin U. Jansen. The network helps show where Kathrin U. Jansen may publish in the future.

Co-authorship network of co-authors of Kathrin U. Jansen

This figure shows the co-authorship network connecting the top 25 collaborators of Kathrin U. Jansen. A scholar is included among the top collaborators of Kathrin U. Jansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathrin U. Jansen. Kathrin U. Jansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Madhi, Shabir A., Eric A. F. Simões, Nicola P. Klein, et al.. (2025). Dynamics of Respiratory Syncytial Virus Illness and Serology During Pregnancy and Infancy in the United States and South Africa. Open Forum Infectious Diseases. 12(7). ofaf386–ofaf386.

Cai, Bing, Yili Chen, Beate Schmöele-Thoma, et al.. (2024). A Statistical Model to Predict Protection Against Infant Respiratory Syncytial Virus Disease Through Maternal Immunization. Vaccines. 12(12). 1351–1351.

Schmöele-Thoma, Beate, Agnieszka Zareba, Qin Jiang, et al.. (2022). Vaccine Efficacy in Adults in a Respiratory Syncytial Virus Challenge Study. New England Journal of Medicine. 386(25). 2377–2386. 79 indexed citations

Peterson, James T., Agnieszka Zareba, David Fitzpatrick, et al.. (2021). Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F Vaccine When Coadministered With a Tetanus, Diphtheria, and Acellular Pertussis Vaccine. The Journal of Infectious Diseases. 225(12). 2077–2086. 31 indexed citations

Essink, Brandon, James T. Peterson, Kari Yacisin, et al.. (2021). A randomized phase 1/2 study of the safety and immunogenicity of a multivalent pneumococcal conjugate vaccine in healthy adults 50 through 85 years of age. Human Vaccines & Immunotherapeutics. 17(8). 2691–2699. 2 indexed citations

Fitzpatrick, David, Daniel A. Scott, Ingrid L. Scully, et al.. (2021). A randomized phase 1 study of the safety and immunogenicity of 2 novel pneumococcal conjugate vaccines in healthy Japanese adults in the United States. Human Vaccines & Immunotherapeutics. 17(7). 2249–2256. 9 indexed citations

Klein, Nicola P., Paula Peyrani, Kari Yacisin, et al.. (2021). A phase 3, randomized, double-blind study to evaluate the immunogenicity and safety of 3 lots of 20-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naive adults 18 through 49 years of age. Vaccine. 39(38). 5428–5435. 53 indexed citations

Thompson, Allison, Joseph M. Severs, Ingrid L. Scully, et al.. (2019). Phase 1 trial of a 20-valent pneumococcal conjugate vaccine in healthy adults. Vaccine. 37(42). 6201–6207. 77 indexed citations

Scully, Ingrid L., Mark Cutler, Todd Belanger, et al.. (2019). 1337. Development, Maintenance, and Application of Opsonophagocytic Assays to Measure Functional Antibody Responses to Support a 20 Valent Pneumococcal Conjugate Vaccine. Open Forum Infectious Diseases. 6(Supplement_2). S484–S484. 6 indexed citations

10.

Dupont, Christopher D., Ingrid L. Scully, Brinda Monian, et al.. (2018). Two Vaccines for Staphylococcus aureus Induce a B-Cell-Mediated Immune Response. mSphere. 3(4). 16 indexed citations

11.

Thompson, Allison, Nicola P. Klein, H. Jackson Downey, et al.. (2018). Coadministration of 13-valent pneumococcal conjugate and quadrivalent inactivated influenza vaccines in adults previously immunized with polysaccharide pneumococcal vaccine 23: a randomized clinical trial. Human Vaccines & Immunotherapeutics. 15(2). 444–451. 16 indexed citations

12.

Tan, Charles Y., Fred Immermann, Shite Sebastian, et al.. (2018). Evaluation of a Validated Luminex-Based Multiplex Immunoassay for Measuring Immunoglobulin G Antibodies in Serum to Pneumococcal Capsular Polysaccharides. mSphere. 3(4). 24 indexed citations

13.

Frenck, Robert W., C. Buddy Creech, Eric Sheldon, et al.. (2016). Safety, tolerability, and immunogenicity of a 4-antigen Staphylococcus aureus vaccine (SA4Ag): Results from a first-in-human randomised, placebo-controlled phase 1/2 study. Vaccine. 35(2). 375–384. 51 indexed citations

14.

Creech, C. Buddy, Robert W. Frenck, Eric Sheldon, et al.. (2016). Safety, tolerability, and immunogenicity of a single dose 4-antigen or 3-antigen Staphylococcus aureus vaccine in healthy older adults: Results of a randomised trial. Vaccine. 35(2). 385–394. 43 indexed citations

15.

Huijts, Susanne M., Wim Boersma, D. E. Grobbee, et al.. (2014). Predicting pneumococcal community-acquired pneumonia in the emergency department. Clinical Microbiology and Infection. 20(12). 1316–1322. 7 indexed citations

16.

Juergens, Christine, Pierre J.T. De Villiers, Keymanthri Moodley, et al.. (2014). Safety and immunogenicity of 13-valent pneumococcal conjugate vaccine formulations with and without aluminum phosphate and comparison of the formulation of choice with 23-valent pneumococcal polysaccharide vaccine in elderly adults. Human Vaccines & Immunotherapeutics. 10(5). 1343–1353. 31 indexed citations

17.

Cooper, David, Xinhong Yu, Mohinder Sidhu, et al.. (2011). The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A. Vaccine. 29(41). 7207–7211. 191 indexed citations

18.

Yeh, Sylvia H., Alejandra Gurtman, David Hurley, et al.. (2010). Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in Infants and Toddlers. PEDIATRICS. 126(3). e493–e505. 186 indexed citations

19.

Tobery, Timothy W., Su Wang, Michael P. Neeper, et al.. (2001). A simple and efficient method for the monitoring of antigen-specific T cell responses using peptide pool arrays in a modified ELISpot assay. Journal of Immunological Methods. 254(1-2). 59–66. 50 indexed citations

20.

Cook, James C., Joseph G. Joyce, Hugh A. George, et al.. (1999). Purification of Virus-like Particles of Recombinant Human Papillomavirus Type 11 Major Capsid Protein L1 from Saccharomyces cerevisiae. Protein Expression and Purification. 17(3). 477–484. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact